Hepatic CYP1A induction in 3-methylcholanthrene-treated transgenic rats with insufficient blood growth hormone

Journal of Toxicologic Pathology

Volumn 14, Issue 2, 2001, Pages 151-155

  Tani, Yoshiro ^a   Yamamoto, Hideki ^a   Kamai, Yoko ^a   Maeda, Naoyuki ^a   Hosokawa, Tsunemichi ^a   Doi, Kunio ^b  

^a DAIICHI SANKYO CO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

3 methylcholanthrene; Cytochrome P450; Mini rats; Ph nobarbital

Indexed keywords

EID: 33845333218     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.14.151     Document Type: Article

References (15)

1. Wells T, Mode A, Floby E, and Robinson 1C. The sensitivity of hepatic CYP2C gene expression to baseline growth hormone (GH) bioactivity in dwarf rats: effects of GHbinding protein in vivo. Endocrinology 1994; 134: 21352141.
2. Oinonen T and Lindros KO. Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. BiochemJ 1995; 309: 55-61.
3. Waxman DJ, Ram PA, Pampori NA, and Shapiro BH. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 1995; 48: 790-797.
4. Yamazoe Y, Murayama N, Shimada M, Imaoka S, Funae Y, and Kato R. Suppression of hepatic levels of an ethanolinducible P-450DM/J by growth hormone: relationship between the increased level of P-450DM/J and depletion of growth hormone in diabetes. Mol Pharmacol 1989; 36: 716722.
5. Yamazoe Y, Murayama N, Shimada M, and Kato R. Thyroid hormone suppression of hepatic levels of phenobarbital-inducible P-450b and P-450e and other neonatal P-450s in hypophysectomized rats. Biochem Biophys Res Commun 1989; 160: 609-614.
6. Uetsuka K, Suzuki M, Nakayama H, and Doi K. Immunohistochemical study on galactosamine-induced subacute hepatitis in rats of Jcl:WistarTgN(ARGHGEN)lNts strain (Mini rats). Exp Anim 1997; 46: 203-209.
7. Matsumoto K, Kakidani H, Anzai M, Nakagata N, Takahashi A, Takahashi Y, and Miyata K. Evaluation of an antisense RNA transgene for inhibiting growth hormone gene expression in transgenic rats. Dev Genet 1995; 16: 273-277.
8. Matsumoto K, Kakidani H, Takahashi A, Nakagata N, Anzai M, Matsuzaki Y, Takahashi Y, Miyata K, Utsumi K, and Iritani A. Growth retardation in rats whose growth hormone gene expression was suppressed by antisense RNA transgene. Mol Reprod Dev 1993; 36: 53-58.
9. Tani Y, Kamai Y, Yamate K, Mizuno H, Yamamoto H, Hosokawa T, and Doi K. Restitutive response of Mini rat liver to injury induced by a single oral administration of thioacetamide. J Toxicol Sei 2001 ; 26: 25-37.
10. Tani Y, Yamamoto H, Kawaji A, Mizuno H, Fukushige J, Hosokawa T, and Doi K. Hepatic cytochrome P450 and flavin-containing monooxygenase in male Nts:Mini rat, a transgenic rat carrying antisense RNA transgene for rat growth hormone. Toxicol Lett 1999; 106: 159-169.
11. Omura T and Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 1964; 239: 2370-2378.
12. Lowry OH, Rosebrough NJ, Fair AL, and Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem 1951; 193: 265-275.
13. Guyonnet D, Belloir C, Suschetet M, Siess MH, and Le-Bon AM. Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation. Mutât Res 2000; 466: 17-26.
14. Astorg P, Gradelet, S, Leclerc J, and Siess MH. Effects of provitamin A or non-provitamin A carotenoids on liver xenobiotic-metabolizing enzymes in mice. Nutr Cancer 1997; 27: 245-249.
15. Smith BJ, Hu JK, and Schwecke WP. Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response. Drug Chem Toxicol 1998:21:291-303.